Qu et al. evaluated the effect of emodin on angiogenesis in human osteosarcoma and found that exogenous HMGB1 supplementation positively promoted angiogenesis in nude mouse grafted tumor tissues, as demonstrated by increased VEGF and vWF expression, which was effectively reversed by emodin treatment. This evidence concerns the gene VEGFA and osteosarcoma.